Researchers are testing a treatment that delivers tiny, dissolvable particles to block those abnormal vessels. In a trial of nearly 200 people, most participants reported meaningful pain improvement that lasted a year. For people seeking to avoid surgery or delay joint replacement, a local, minimally invasive option could change how clinicians manage chronic knee pain.
This topic matters because treatments that spare healthy tissue and restore function reshape long-term recovery and daily life. Learn how this approach works, who might benefit, and what the outcomes mean for access and rehabilitation to see how it could fit into broader efforts to enhance mobility and inclusion for people living with arthritis.
A promising new treatment for knee arthritis uses tiny, dissolvable particles to block abnormal blood vessels, easing inflammation and pain without joint replacement surgery. In a study of 194 patients, 80% experienced clinically meaningful pain relief lasting at least 12 months.
